The Latest
The WasteWatcherAnother Year and Additional F-35 Complications
Add one more item to the list of innumerable glitches in Lockheed Martin’s F-35 Joint Strike Fighter (JSF) program.
Press ReleaseCitizens Against Government Waste Statement on C-Band Proposal
This proposal is imperative to ensure that the U.S. remains the leader in 5G.
The WasteWatcherCBO’s 2020 Economic Outlook Shows Trillion-Dollar Deficits Are Here To Stay
Unsurprisingly, the United States’ fiscal outlook remains dreadful.
The WasteWatcherCaps on Consumer Loans Hurt More Than They Help
H.R. 5050, the Veterans and Consumers Fair Credit Act, would extend the 36 percent usury annual percentage rate (APR) cap under the 2006 Military Lending Act (MLA) to all consumers, stifling credit access for those that need it most.
Press ReleaseCitizens Against Government Waste Reacts to the State of the Union
Thank you President Trump for lifting up the nation economically and fighting against socialism.
Op-EdsDo Not Stop Progress on 5G
C4ISRNET: Without the FCC’s rulemaking on the 5.9 GHz band, automotive safety applications using C-V2X will continue to suffer.
The WasteWatcherThe IPI - Are We All Socialists Now?
Adopting these policies would validate socialized medicine schemes like price controls and rationing.
Agency CommentsComment to CMS - Medicaid Fiscal Accountability Regulation (MFAR)
Medicaid is a federal and state funded program but is administered by the states.
Op-EdsD.C. Council Should Not Soak Taxpayers with New Beverage Excise Tax
InsideSources: A soda tax does not prevent people from drinking what they want.
Press ReleaseCAGW Praises President Trump for Signing USMCA
Today, President Trump signed the USMCA into law, marking another promise kept and a major legislative victory.
Press ReleaseCAGW Announces New Vice President of Policy and Government Affairs
Today, Citizens Against Government Waste announced the promotion of Deborah Collier to be VP of Policy and Government Affairs.
Agency CommentsCoalition Comments on Biosimilar and Interchangeable Insulin Guidance
CAGW and coalition partners share the FDA's deep commitment to the development of a robust biosimilars market and appreciate the Agency’s work to develop an efficient approval pathway for biosimilars to bring savings and access to America’s patients.
